HER2 Gene News and Research

RSS
The HER2 (human epidermal growth factor receptor 2) gene is part of a family of genes that play roles in regulating cell growth. The protein it makes is a tyrosine kinase growth factor receptor that a number of normal tissues express and which probably has a role in normal cell function, regulating growth and proliferation.
Researchers offer critical new information about head and neck squamous cell cancer

Researchers offer critical new information about head and neck squamous cell cancer

Trastuzumab drug improves long-term survival of patients with HER-2 positive breast cancer

Trastuzumab drug improves long-term survival of patients with HER-2 positive breast cancer

TCGA Research Network identify new potential therapeutic targets for major form of bladder cancer

TCGA Research Network identify new potential therapeutic targets for major form of bladder cancer

Researchers identify potentially treatable subtype of pancreatic cancer

Researchers identify potentially treatable subtype of pancreatic cancer

Bazedoxifene used for treating osteoporosis stops growth of breast cancer cells

Bazedoxifene used for treating osteoporosis stops growth of breast cancer cells

Cells with amplified HER2 gene need to be considered carefully, study says

Cells with amplified HER2 gene need to be considered carefully, study says

Newly discovered ‘master regulator’ gene may help develop novel treatment for drug-resistant tumors

Newly discovered ‘master regulator’ gene may help develop novel treatment for drug-resistant tumors

Study suggests lung cancer patients with HER2 mutations may benefit from anti-HER2 drugs

Study suggests lung cancer patients with HER2 mutations may benefit from anti-HER2 drugs

Biological markers for triple-negative breast cancer (TNBC): an interview with Alexandre Templier, CEO of Quinten

Biological markers for triple-negative breast cancer (TNBC): an interview with Alexandre Templier, CEO of Quinten

Subcutaneous administration of Herceptin preferred by HER2-positive breast cancer patients over IV

Subcutaneous administration of Herceptin preferred by HER2-positive breast cancer patients over IV

Study details exactly how Her2 gene promotes progression and spread of breast cancer cells

Study details exactly how Her2 gene promotes progression and spread of breast cancer cells

Renowned biotech researcher to receive TJU's Lennox K. Black International Prize

Renowned biotech researcher to receive TJU's Lennox K. Black International Prize

Obesity and breast cancer recurrence: an interview with Dr. Joseph Sparano

Obesity and breast cancer recurrence: an interview with Dr. Joseph Sparano

Herceptin® (trastuzumab) delivery methods: an interview with Dr Gustavo Ismael

Herceptin® (trastuzumab) delivery methods: an interview with Dr Gustavo Ismael

Personalized medicine and the Human Genome Project

Personalized medicine and the Human Genome Project

TGen to present TNBC study at AACR 2012 annual meeting

TGen to present TNBC study at AACR 2012 annual meeting

Positive results from Synta's Ganetespib Phase 2 trial on HER2-positive and triple negative mBC

Positive results from Synta's Ganetespib Phase 2 trial on HER2-positive and triple negative mBC

Herceptin chemo combination could mean longer survival and lower side effects in breast cancer patients: Study

Herceptin chemo combination could mean longer survival and lower side effects in breast cancer patients: Study

Breast cancer drug combination could stop cancer “in its tracks”

Breast cancer drug combination could stop cancer “in its tracks”

Novel studies explore new targets to prevent spread of breast cancer

Novel studies explore new targets to prevent spread of breast cancer